Dysregulated Protease Homeostasis Defines Primary FSGS.
Saved in:
| Title: | Dysregulated Protease Homeostasis Defines Primary FSGS. |
|---|---|
| Authors: | Schmidt J; Department of Preclinical Development and Validation, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany., Sopel N; Department of Nephrology and Hypertension, Uniklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany., Rist C; Department of Nephrology and Hypertension, Uniklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany., Ohs A; Department of Nephrology and Hypertension, Uniklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.; Research Center on Rare Kidney Diseases (RECORD), Uniklinikum Erlangen, Erlangen, Germany., Dawid L; Department of Preclinical Development and Validation, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Institute for Bioanalysis, University of Applied Sciences Coburg, Coburg, Germany., Simm S; Institute for Bioanalysis, University of Applied Sciences Coburg, Coburg, Germany., Catanese L; Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany., Rupprecht H; Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany.; Kuratorium for Dialysis and Transplantation (KfH) Bayreuth, Bayreuth, Germany., Jobst-Schwan T; Department of Nephrology and Hypertension, Uniklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany., Lehmann J; Department of Preclinical Development and Validation, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Leipzig, Germany., Daniel C; Department of Nephropathology, Uniklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany., Kalkhof S; Department of Preclinical Development and Validation, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Institute for Bioanalysis, University of Applied Sciences Coburg, Coburg, Germany.; Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany., Schiffer M; Department of Nephrology and Hypertension, Uniklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.; Research Center on Rare Kidney Diseases (RECORD), Uniklinikum Erlangen, Erlangen, Germany., Müller-Deile J; Department of Nephrology and Hypertension, Uniklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.; Research Center on Rare Kidney Diseases (RECORD), Uniklinikum Erlangen, Erlangen, Germany. |
| Source: | Kidney360 [Kidney360] 2026 Mar 01; Vol. 7 (3), pp. 487-500. Date of Electronic Publication: 2025 Nov 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 101766381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2641-7650 (Electronic) Linking ISSN: 26417650 NLM ISO Abbreviation: Kidney360 Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
